<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04586738</url>
  </required_header>
  <id_info>
    <org_study_id>Implants in deep sclerectomy</org_study_id>
    <nct_id>NCT04586738</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of Non-resorbable Uveoscleral Implant Versus Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy</brief_title>
  <official_title>Comparative Clinical Trial on the Efficacy and Safety of Non-resorbable Uveoscleral Implant Associated With Absorbable Collagen Matrix vs Isolated Absorbable Collagen Matrix in Non-perforating Deep Sclerectomy in Glaucoma Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Germans Trias i Pujol Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate and compare the hypotensive efficacy at 24 months between&#xD;
      non-perforating deep sclerectomy surgery with non-resorbable uveoscleral implant associated&#xD;
      with absorbable collagen matrix versus non-perforating deep sclerectomy surgery with isolated&#xD;
      absorbable collagen matrix implant.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate and compare the hypotensive efficacy at 24 months&#xD;
      between two implants in glaucoma surgery. Non-perforating deep sclerectomy surgery with&#xD;
      non-resorbable uveoscleral implant associated with absorbable collagen matrix versus&#xD;
      non-perforating deep sclerectomy surgery with isolated absorbable collagen matrix implant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Evaluations will be done an outcome assessor that do not know the intervention group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Intraocular pressure</measure>
    <time_frame>24 hours after surgery, 3 months, 12 months, 24 months</time_frame>
    <description>Comparison of intraocular pressure measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of adverse events</measure>
    <time_frame>24 hours after surgery, 3 months, 12 months, 24 months</time_frame>
    <description>Adverse events spontaneous by subject (Safety and tolerability)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Non-resorbable uveoscleral implant associated with absorbable collagen matrix</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>non-perforating deep sclerectomy surgery with non-resorbable uveoscleral implant associated with absorbable collagen matrix</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Isolated absorbable collagen matrix implant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>non-perforating deep sclerectomy surgery with isolated absorbable collagen matrix implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>non-perforating deep sclerectomy surgery</intervention_name>
    <description>Non-penetrating deep sclerectomy is a non-perforating filtration procedure used for the surgical treatment of medically uncontrolled open angle glaucoma.This surgery is performed to facilitate the outflow of aqueous humour from the anterior chamber to the subconjunctival space through a natural membrane (trabeculo-Descemet's window). This enables a more physiological reduction of intraocular pressure to be achieved.</description>
    <arm_group_label>Isolated absorbable collagen matrix implant</arm_group_label>
    <arm_group_label>Non-resorbable uveoscleral implant associated with absorbable collagen matrix</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients older than 18 years of age&#xD;
&#xD;
          -  Primary or secondary open-angle glaucoma&#xD;
&#xD;
          -  High intraocular pressure (greater than or equal to 18mmHg) despite using maximum&#xD;
             medical treatment&#xD;
&#xD;
          -  Intolerance to medication.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with previous glaucoma surgery&#xD;
&#xD;
          -  Previous ocular surgery in the last 6 months&#xD;
&#xD;
          -  Previous history of Laser trabeculoplasty in the last 12 months&#xD;
&#xD;
          -  Moderate or severe diabetic retinopathy&#xD;
&#xD;
          -  Active or recurrent eye disease (uveitis)&#xD;
&#xD;
          -  Plateau iris&#xD;
&#xD;
          -  Ocular neovascularization&#xD;
&#xD;
          -  Aphakia&#xD;
&#xD;
          -  Neovascular angle-closure glaucoma&#xD;
&#xD;
          -  Previous history of intraocular or extraocular malignant neoplasm&#xD;
&#xD;
          -  Pregnancy or lactation period, axial length&gt; 26mm and &lt;20mm&#xD;
&#xD;
          -  Unwillingness for participating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jéssica Botella García, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Germans Trias i Pujol Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jéssica Botella García, MD</last_name>
    <phone>+34691801518</phone>
    <email>Jessicabotga@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jordi Loscos, MD</last_name>
    <phone>+34691801518</phone>
    <email>jordiloscos4@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jéssica Botella García</name>
      <address>
        <city>Barcelona</city>
        <zip>08391</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jéssica Botella</last_name>
      <phone>691801518</phone>
      <email>Jessicabotga@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Germans Trias i Pujol</name>
      <address>
        <city>Barcelona</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jéssica B García</last_name>
      <phone>691801518</phone>
      <email>Jessicabotga@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 7, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>February 16, 2021</last_update_submitted>
  <last_update_submitted_qc>February 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

